Table 2 Short-term surgical outcomes of NE and E patients who underwent gastrectomy for pT1-T2 gastric cancer
Factors | Group NE (< 70 years) | Group E (≥ 70 years) | p value | |
|---|---|---|---|---|
Operation time: min (mean ± SD; min-max) | 146.9 ± 41.58 | 143.72 ± 44.53 | 0.432 | |
Blood loss: ml (mean ± SD; min-max) | 171.82 ± 137.11 | 169.50 ± 136.50 | 0.879 | |
ICU stay: days (mean ± SD; min-max) | 1.24 ± 1.24 | 2.23 ± 6.30 | 0.014 | |
Postoperative hospital stay: days (mean ± SD; min-max) | 13.07 ± 5.86 | 14.05 ± 8.24 | 0.145 | |
Dissected lymph nodes (mean ± SD) | 22.18 ± 10.28 | 19.50 ± 9.43 | 0.005 | |
Curability | R0 | 259 (97.0%) | 182 (95.8%) | 0.484 |
R1,2 | 8 (3.0%) | 8 (4.2%) | ||
Postoperative complications: n (%) | 55/267 (20.5%) | 51/190 (26.8%) | 0.144 | |
Surgical complications | 29/267 (10.8%) | 20/190 (10.5%) | 0.909 | |
Anastomotic leakage | 2/267 (0.7%) | 5/190 (2.6%) | 0.133 | |
Postoperative bleeding | 6/267 (2.2%) | 4/190 (2.1%) | 0.999 | |
Peritonitis/ intraabdominal abscess | 5/267 (1.8%) | 3/190 (1.5%) | 0.999 | |
Ileus | 3/267 (1.1%) | 0/190 (0.0%) | 0.269 | |
Incisional surgical site infection and (or) eventration | 5/267 (1.8%) | 4/190 (2.1%) | 0.999 | |
Postoperative pancreatitis | 5/267 (1.8%) | 2/190 (1.0%) | 0.704 | |
Pancreatic/biliary/enterocutaneuos fistula | 3/267 (1.1%) | 2/190 (1.0%) | 0.999 | |
Medical complications | 26/267 (9.7%) | 31/190 (16.3%) | 0.043 | |
Cardiac insufficiency | 0/267 (0.0%) | 3/190 (1.5%) | 0.071 | |
Pneumonia | 11/267 (4.1%) | 4/190 (2.1%) | 0.292 | |
Sepsis | 0/267 (0.0%) | 3/190 (1.5%) | 0.071 | |
PATE | 0/267 (0.0%) | 2/190 (1.0%) | 0.172 | |
Other | 15/267 (5.6%) | 19/190 (10.0%) | 0.102 | |
Clavien-Dindo | 1–2 | 39 (14.6%) | 30 (15.8%) | 0.195 |
3–4 | 16 (6.0%) | 10 (5.3%) | ||
Postoperative mortality: n (%) | 0 (0.0%) | 11 (5.7%) | 0.001 | |